These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16261949)

  • 21. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
    Mix JA; Crews WD
    J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginkgo biloba for prevention of dementia: a systematic review and meta-analysis.
    Charemboon T; Jaisin K
    J Med Assoc Thai; 2015 May; 98(5):508-13. PubMed ID: 26058281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults.
    Carlson JJ; Farquhar JW; DiNucci E; Ausserer L; Zehnder J; Miller D; Berra K; Hagerty L; Haskell WL
    J Am Diet Assoc; 2007 Mar; 107(3):422-32. PubMed ID: 17324660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Final IQWiG to Ginkgo biloba].
    Winckler T
    Pharm Unserer Zeit; 2009; 38(5):454-61. PubMed ID: 19711323
    [No Abstract]   [Full Text] [Related]  

  • 26. The Hawthorne Effect: a randomised, controlled trial.
    McCarney R; Warner J; Iliffe S; van Haselen R; Griffin M; Fisher P
    BMC Med Res Methodol; 2007 Jul; 7():30. PubMed ID: 17608932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
    Napryeyenko O; Borzenko I;
    Arzneimittelforschung; 2007; 57(1):4-11. PubMed ID: 17341003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective.
    Lautenschlager NT; Ihl R; Müller WE
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S46-50. PubMed ID: 22784429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.
    Yancheva S; Ihl R; Nikolova G; Panayotov P; Schlaefke S; Hoerr R;
    Aging Ment Health; 2009 Mar; 13(2):183-90. PubMed ID: 19347685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
    Schreiter Gasser U; Gasser T
    Fortschr Med Orig; 2001 Nov; 119(3-4):135-8. PubMed ID: 11789125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of Ginkgo biloba extract in acute ischemic stroke.
    Liu J
    Explore (NY); 2006 May; 2(3):262-3. PubMed ID: 16781654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary assessment of ginkgo biloba (Ginkofar) in patients with dementia].
    Bidzan L; Biliekiewicz A; Turczyński J
    Psychiatr Pol; 2005; 39(3):559-66. PubMed ID: 16149765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ginkgo biloba special extract EGb 761--an anti-dementia drug].
    Hörr R; Kieser M
    Fortschr Med; 1998 Jan; 116(3):39-40. PubMed ID: 9522547
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761)].
    Orendorz-Fraczkowska K; Pośpiech L; Gawron W
    Otolaryngol Pol; 2002; 56(1):83-8. PubMed ID: 12053674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Ginkgo Biloba Extract Prescriptions and Dementia Incidence in Outpatients with Mild Cognitive Impairment in Germany: A Retrospective Cohort Study.
    Bohlken J; Peters O; Kostev K
    J Alzheimers Dis; 2022; 86(2):703-709. PubMed ID: 35124648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical data in early intervention.
    Kasper S
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S41-5. PubMed ID: 22784428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine.
    Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E
    Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study.
    Canevelli M; Adali N; Kelaiditi E; Cantet C; Ousset PJ; Cesari M;
    Phytomedicine; 2014 May; 21(6):888-92. PubMed ID: 24548724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of drugs against dementia on cognition in aging and mild cognitive impairment.
    Ihl R
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S38-43. PubMed ID: 13130387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.